Health Care: Drugs

Medivation Inc (MDVN: NASDAQ)

$41.3 n/a | n/a%
10/12/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 41.30
52 Week High 70.79
52 Week Low 38.08
Avg. Daily Vol. (Mil) 2.41
Beta (3 year) 0.99
Share Related Items
Mkt Cap (Mil) 6,747.96
Shares Out (Mil) 163.39
Float (Mil) 131.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.50
Current Ratio 2.60
LT Debt/ Equity 0.03
Total Debt / Equity 0.32
Valuation Ratios
Price Earnings 26.70
Price/Sales 8.65
Price/Book 12.79
Price/Cash Flow 24.20
Per Share Data
Earnings 1.54
Sales 4.77
Book Value 3.23
Cash Flow 1.71
Business Summary
Medivation Inc is a biopharmaceutical company engaged in the development of novel small molecule drugs to treat diseases like Alzheimer's disease and Huntington disease.
General Information
36th Floor, 525 Market Stree
San Francisco, CA 94105
Industry : Drugs
Sector: Health Care
Employees: 485
CEO: Dr. David T. Hung,M.D.
Short Interest
Current Month (Mil) 5.73
Previous Month (Mil) 3.85
Short Interest Ratio (Days) 2.40
Management Effectiveness
Return on Equity 50.20
Return on Assets 28.50
Return on Investments 48.70
Gross Margin n.a.
EBIT Margin 34.40
Profit Margin 34.00

Portfolios with MDVN

Latest MDVN Headlines from TheStreet

More Financial News for MDVN

Press Releases for MDVN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter